CompletedPhase 4NCT01540838

Slow Initial β-lactam Infusion With High-dose Paracetamol to Improve the Outcomes of Childhood Bacterial Meningitis

Studying Pneumococcal meningitis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of Helsinki
Principal Investigator: Heikki O Peltola, MD, PhD
Childrens Hospital of Helsinki University Central Hospital
Intervention: Infusion with paracetamol(drug)
Enrollment: 375 target
Eligibility: 15 years · All sexes
Timeline: 2012 – 2017

Study locations (1)

Hospital Pediatrico David Bernardino, Luanda, Angola

Collaborators

Foundation for Paediatric Research, Finland

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01540838 on ClinicalTrials.gov

Other trials for Pneumococcal meningitis

Additional recruiting or active studies for the same condition.

RECRUITINGNCT00901602
Lebanese Interhospital Pneumococcal Surveillance Program
American University of Beirut Medical Center

See all trials for Pneumococcal meningitis →

← Back to all trials